Rough set-based SAR analysis: An inductive method

Expert Systems with Applications

Volumn 37, Issue 7, 2010, Pages 5032-5039

  Dong, Ying ^a   Xiang, Bingren ^a   Wang, Teng ^a   Liu, Hao ^b   Qu, Lingbo ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Guangdong Vocational College of Chemical Engineering and Pharmaceutics   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cyclin dependent kinase; Feature selection; Indirubins; Rough set; Structure activity relationship

Indexed keywords

10-FOLD CROSS-VALIDATION; 3D-QSAR; COCRYSTAL STRUCTURE; CYCLIN-DEPENDENT KINASE; DATA PREPROCESSING; FEATURE SELECTION; HUMAN-READABLE; IF-THEN RULES; INDIRUBIN; INDUCTIVE METHOD; LEAVE-ONE-OUT; LOGITBOOST; ROUGH SET; RULE BASED; RULE GENERATOR; STRUCTURE ACTIVITY RELATIONSHIPS; SUPPORT VECTOR CLASSIFIERS; TEST SETS;

DECISION TREES; MOLECULAR GRAPHICS; NEURAL NETWORKS; THREE DIMENSIONAL;

ROUGH SET THEORY;

EID: 77950188653     PISSN: 09574174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eswa.2009.12.008     Document Type: Article

References (27)

1. Beauchard A., Ferandin Y., Frère S., Lozach O., Blairvacq M., Meijer L., et al. Synthesis of novel 5-substituted indirubins as protein kinases inhibitors. Bioorganic and Medicinal Chemistry 14 (2006) 6434-6443
2. Chen H.H., Wong Y.H., Geneviere A.M., and Fann M.J. CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. Biochemical and Biophysical Research Communications 354 (2007) 735-740
3. Davies T.G., Tunnah P., Meijer L., Marko D., Eisenbrand G., Endicott J.A., et al. Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate. Structure 9 (2001) 389-397
4. Ferandin Y., Bettayeb K., Kritsanida M., Lozach O., Polychronopoulos P., Magiatis P., et al. 3′-Substituted 7-halogenoindirubins, a new class of cell death inducing agents. Journal of Medicinal Chemistry 49 (2006) 4638-4649
5. Fernández M., Caballero J., and Tundidor-Camba A. Linear and nonlinear QSAR study of N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives as matrix metalloproteinase inhibitors. Bioorganic and Medicinal Chemistry 14 (2006) 4137-4150
6. Hoessel R., Leclerc S., Endicott J.A., Nobel M.E.M., Lawrie A., Tunnah P., et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nature Cell Biology 1 (1999) 60-67
7. Johnson S.R. The trouble with QSAR (or how I learned to stop worrying and embrace fallacy). Journal of Chemical Information and Modeling 48 (2008) 25-26
8. Johnson L.N., Moliner E.D., Brown N.R., Song H.W., Barford D., Endicott J.A., et al. Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2. Pharmacology and Therapeutics 93 (2002) 113-124
9. Kubinyi H. From narcosis to hyperspace: The history of QSAR. Quantitative Structure-Activity Relationships 21 (2002) 348-356
10. Liu H., Xiang B.R., and Qu L.B. The application of rough sets in SAR analysis of N1-site substituted fluoroquinolones. Chemometrics and Intelligent Laboratory Systems 87 (2007) 155-160
11. Malumbres M., Pevarello P., Barbacid M., and Bischoff J.R. CDK inhibitors in cancer therapy: What is next?. Trends in Pharmacological Sciences 29 (2007) 16-21
12. Mapelli M., Massimiliano L., Crovace C., Seeliger M.A., Tsai L.H., Meijer L., et al. Mechanism of CDK5/p25 binding by CDK inhibitors. Journal of Medicinal Chemistry 48 (2005) 671-679
13. Michielan L., Bacilieri M., Schiesaro A., Bolcato C., Pastorin G., Spalluto G., et al. Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor. Journal of Chemical Information and Modeling 48 (2008) 350-363
14. Monaco III E.A., and Vallano M.L. Role of protein kinases in neurodegenerative disease: Cyclin-dependent kinases in Alzheimer's disease. Frontiers in Bioscience 10 (2005) 143-159
15. Moshinsky D.J., Bellamacina C.R., Boisvert D.C., Huang P., Hui T., Jancarik J., et al. SU9516: biochemical analysis of cdk inhibition and crystal structure in complex with cdk2. Biochemical and Biophysical Research Communications 310 (2003) 1026-1031
16. Pattaraintakorn P., and Cercone N. Integrating rough set theory and medical applications. Applied Mathematics Letters 21 (2008) 400-403
17. Pawlak Z. Rough set approach to knowledge-based decision support. European Journal of Operational Research 99 (1997) 48-57
18. Pawlak Z. Rough set theory and its applications. Journal of Telecommunications and Information Technology 3 (2002) 7-10
19. Polychronopoulos P., Magiatis P., Skaltsounis A.L., Myrianthopoulos V., Mikros E., Tarricone A., et al. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. Journal of Medicinal Chemistry 47 (2004) 935-946
20. Schang L.M. Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication. Biochimica et Biophysica Acta 1697 (2004) 197-209
21. Shen Q., and Jensen R. Rough sets, their extensions and applications. International Journal of Automation and Computing 4 (2007) 100-106
22. Strömbergsson H., Prusis P., Midelfart H., Lapinsh M., Wikberg J.E.S., and Komorowski J. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions. PROTEINS: Structure, Function, and Bioinformatics 63 (2006) 24-34
23. Thangavel K., and Pethalakshmi A. Dimensionality reduction based on rough set theory: A review. Applied Soft Computing 9 (2009) 1-12
24. Toogood P.L. Cyclin-dependent kinase inhibitors for treating cancer. Medicinal Research Reviews 21 (2001) 487-498
25. Walczak B., and Massart D.L. Tutorial: Rough sets theory. Chemometrics and Intelligent Laboratory Systems 47 (1999) 1-16
26. Witten I.H., and Frank E. Data mining: Practical machine learning tools and techniques. 2nd ed. (2005), Morgan Kaufmann, San Francisco
27. Yahia M.E., Mahmod R., Sulaiman N., and Ahmad F. Rough neural expert systems. Expert Systems with Applications 18 (2000) 87-99